berberine/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
Decreases C-reactive protein concentration
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Findingreplicated ×2“From the baseline to the 8th week, the plasma CRP concentration decreased in the berberine group, while increased in the placebo group (F = 5.373; p = 0.024).”
Quoted verbatim from Improvement of adjunctive berberine treatment on negative symptoms in patients with schizophrenia.. - Study
- RCT
- Duration
- 8 weeks
- Dose
- berberine 900 mg/day, oral, 8 weeks
- Population
- patients with schizophrenia, berberine given adjunctive to a single atypical antipsychotic drug
Improvement of adjunctive berberine treatment on negative symptoms in patients with schizophrenia.2022PMID:35037116Permalink
Keep reading
- Everything the graph holds on berberine
- Every compound studied against C-reactive protein concentration
- How to read the evidence strength and the marks
To cite this finding: https://catalystproject.ai/e/01M2P9B32T6NBQGPESYGW3MAN3